Literature DB >> 32312766

MicroRNA-155 Deficiency Exacerbates Trypanosoma cruzi Infection.

Bijay K Jha1, Sanjay Varikuti2, Abhay R Satoskar3, Bradford S McGwire4, Gabriella R Seidler2, Greta Volpedo2.   

Abstract

Chagas disease, caused by the intracellular protozoan parasite Trypanosoma cruzi, is a public health problem affecting 6 to 8 million people, mainly in Latin America. The role of microRNAs in the pathogenesis of Chagas disease has not been well described. Here, we investigate the role of microRNA-155 (miR-155), a proinflammatory host innate immune regulator responsible for T helper type 1 and type 17 (Th1 and Th17) development and macrophage responses during T. cruzi infection. For this, we compared the survival and parasite growth and distribution in miR-155-/- and wild-type (WT) C57BL/6 mice. The lack of miR-155 caused robust parasite infection and diminished survival of infected mice, while WT mice were resistant to infection. Immunological analysis of infected mice indicated that, in the absence of miR-155, there was decreased interferon gamma (IFN-γ) and tumor necrosis factor alpha (TNF-α) production. In addition, we found that there was a significant reduction of CD8-positive (CD8+) T cells, natural killer (NK) cells, and NK-T cells and increased accumulation of neutrophils and inflammatory monocytes in miR-155-/- mice. Collectively, these data indicate that miR-155 is an important immune regulatory molecule critical for the control of T. cruzi infection.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Chagas disease; Trypanosoma cruzi; immune response; miR-155; microRNA

Year:  2020        PMID: 32312766      PMCID: PMC7309613          DOI: 10.1128/IAI.00948-19

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  Killer lymphocytes use granulysin, perforin and granzymes to kill intracellular parasites.

Authors:  Farokh Dotiwala; Sachin Mulik; Rafael B Polidoro; James A Ansara; Barbara A Burleigh; Michael Walch; Ricardo T Gazzinelli; Judy Lieberman
Journal:  Nat Med       Date:  2016-01-11       Impact factor: 53.440

2.  Chagas' Disease.

Authors:  Caryn Bern
Journal:  N Engl J Med       Date:  2015-11-05       Impact factor: 91.245

3.  Glycoconjugates isolated from Trypanosoma cruzi but not from Leishmania species membranes trigger nitric oxide synthesis as well as microbicidal activity in IFN-gamma-primed macrophages.

Authors:  M M Camargo; A C Andrade; I C Almeida; L R Travassos; R T Gazzinelli
Journal:  J Immunol       Date:  1997-12-15       Impact factor: 5.422

Review 4.  Monocyte recruitment during infection and inflammation.

Authors:  Chao Shi; Eric G Pamer
Journal:  Nat Rev Immunol       Date:  2011-10-10       Impact factor: 53.106

5.  Signal transducer and activator of transcription 1 (STAT-1) plays a critical role in control of Trypanosoma cruzi infection.

Authors:  Manjusha M Kulkarni; Sanjay Varikuti; Cesar Terrazas; Jennifer L Kimble; Abhay R Satoskar; Bradford S McGwire
Journal:  Immunology       Date:  2015-06       Impact factor: 7.397

6.  Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/"indeterminate" and Chagas disease cardiomyopathy patients.

Authors:  Renata Cristina Ferreira; Barbara M Ianni; Lucia C J Abel; Paula Buck; Charles Mady; Jorge Kalil; Edecio Cunha-Neto
Journal:  Mem Inst Oswaldo Cruz       Date:  2003-07-18       Impact factor: 2.743

Review 7.  Chagas disease.

Authors:  José A Pérez-Molina; Israel Molina
Journal:  Lancet       Date:  2017-06-30       Impact factor: 79.321

8.  Ly6Chi inflammatory monocytes promote susceptibility to Leishmania donovani infection.

Authors:  Cesar Terrazas; Sanjay Varikuti; Steve Oghumu; Heidi M Steinkamp; Nurittin Ardic; Jennifer Kimble; Hira Nakhasi; Abhay R Satoskar
Journal:  Sci Rep       Date:  2017-10-31       Impact factor: 4.379

9.  MiR-155 Regulates PAD4-Dependent Formation of Neutrophil Extracellular Traps.

Authors:  Avin Hawez; Amr Al-Haidari; Raed Madhi; Milladur Rahman; Henrik Thorlacius
Journal:  Front Immunol       Date:  2019-11-01       Impact factor: 7.561

10.  Modulation of CD4(+) T cell-dependent specific cytotoxic CD8(+) T cells differentiation and proliferation by the timing of increase in the pathogen load.

Authors:  Fanny Tzelepis; Pedro M Persechini; Mauricio M Rodrigues
Journal:  PLoS One       Date:  2007-04-25       Impact factor: 3.240

View more
  5 in total

1.  MicroRNA-155 contributes to host immunity against Toxoplasma gondii.

Authors:  Yanan Xu; Junhua Wu; Xiaoqi Yuan; Wenyuan Liu; Jiewen Pan; Binbin Xu
Journal:  Parasite       Date:  2021-12-15       Impact factor: 3.000

2.  Epigenetic regulation of transcription factor binding motifs promotes Th1 response in Chagas disease cardiomyopathy.

Authors:  Pauline Brochet; Barbara Maria Ianni; Laurie Laugier; Amanda Farage Frade; João Paulo Silva Nunes; Priscila Camillo Teixeira; Charles Mady; Ludmila Rodrigues Pinto Ferreira; Quentin Ferré; Ronaldo Honorato Barros Santos; Andreia Kuramoto; Sandrine Cabantous; Samuel Steffen; Antonio Noedir Stolf; Pablo Pomerantzeff; Alfredo Inacio Fiorelli; Edimar Alcides Bocchi; Cristina Wide Pissetti; Bruno Saba; Darlan da Silva Cândido; Fabrício C Dias; Marcelo Ferraz Sampaio; Fabio Antônio Gaiotto; José Antonio Marin-Neto; Abílio Fragata; Ricardo Costa Fernandes Zaniratto; Sergio Siqueira; Giselle De Lima Peixoto; Vagner Oliveira-Carvalho Rigaud; Fernando Bacal; Paula Buck; Rafael Ribeiro Almeida; Hui Tzu Lin-Wang; André Schmidt; Martino Martinelli; Mario Hiroyuki Hirata; Eduardo Antonio Donadi; Alexandre Costa Pereira; Virmondes Rodrigues Junior; Denis Puthier; Jorge Kalil; Lionel Spinelli; Edecio Cunha-Neto; Christophe Chevillard
Journal:  Front Immunol       Date:  2022-08-22       Impact factor: 8.786

3.  Circulating MicroRNAs and myocardial involvement severity in chronic Chagas cardiomyopathy.

Authors:  Sergio Alejandro Gómez-Ochoa; Paula Katherine Bautista-Niño; Lyda Z Rojas; Lukas Hunziker; Taulant Muka; Luis E Echeverría
Journal:  Front Cell Infect Microbiol       Date:  2022-08-08       Impact factor: 6.073

4.  Circulating miR-146a as a possible candidate biomarker in the indeterminate phase of Chagas disease.

Authors:  Martha Alicia Ballinas-Verdugo; Rogelio Frank Jiménez-Ortega; Eduardo Martínez-Martínez; Nancy Rivas; Erick Abraham Contreras-López; Roxana Carbó; Fausto Sánchez; Rafael Bojalil; Ricardo Márquez-Velasco; Fausto Sánchez-Muñoz; Ricardo Alejandre-Aguilar
Journal:  Biol Res       Date:  2021-07-21       Impact factor: 5.612

5.  Multi-therapeutic strategy targeting parasite and inflammation-related alterations to improve prognosis of chronic Chagas cardiomyopathy: a hypothesis-based approach.

Authors:  Joseli Lannes-Vieira
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-03-23       Impact factor: 2.743

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.